Epidurals for laparoscopic colorectal surgery 25
Miniabstract 26
128 patients undergoing elective laparoscopic colorectal resections were randomized 27 to epidural (EDA) versus patient-controlled opioid-based analgesia (PCA). Medical 28 recovery and high dependency stay were longer in EDA patients but hospital stay 29 was similar. 30% of EDA patients needed transitory vasopressor treatment. There 30 was no difference in postoperative pain scores. 31
Introduction 58
Enhanced recovery (ERAS ® ) pathways have proven to reduce significantly 59 complications, postoperative length of stay and costs after colorectal surgery [1] [2] [3] . The 60 multimodal treatment bundle contains about 20 individual items to attenuate surgical 61 stress response and thus to improve recovery 4, 5 . High compliance with the 62 recommended pathway was strongly correlated with favorable clinical outcomes 6 . 63
Previous randomized trials identified optimized fluid management, minimal invasive 64 surgery, and epidural analgesia (EDA) as key items of ERAS ® concepts 2, 7 . 65
The benefit of EDA however remains controversial especially when combined 66 with minimal invasive surgery [8] [9] [10] [11] [12] . Expert laparoscopic centers have reported 67 excellent outcomes without use of EDA [13] [14] [15] [16] . Moreover, a recent prospective study 68 suggested even slower recovery if EDA was employed after laparoscopic 69 colectomy 16 . Furthermore, novel strategies for pain management rendered promising 70 results 17, 18 . This obvious mismatch of recommendations, available evidence and 71 current practice can only be reconciled with more prospective data. 72
73
The aim of this prospective randomized trial was therefore to test the 74 hypothesis that EDA improves recovery after laparoscopic colorectal resections when 75 compared with patient-controlled opioid-based analgesia (PCA). 76
5
For medical and logistic reasons, blinding was not performed, as it appeared neither 103 feasible nor realistic for this present study. 104
105
Interventions, anesthesia and pain strategy 106
Patients were randomized the day prior to surgery to allow for appropriate 107 information on the anesthesia technique. 108
In the EDA group, epidural catheter was inserted at thoracic level (Th 8-10) 109 before induction of anesthesia. A bolus of 5ml of bupivacaine 0.5% was started as 110 soon as the epidural catheter was in place, and a continuous perfusion of 111 bupivacaine 0.5% at 5 ml/h was initiated until the end of surgical procedure. 112
In both groups, induction of anesthesia was performed with propofol 1-2 113 mg/kg, fentanyl 2-3 µg/kg and cisatracurium (0.15-0.2 mg/kg) for muscle paralysis. 114
After tracheal intubation, maintenance of anesthesia was performed with sevoflurane 115 in a mixed oxygen/air fresh gaz, and cisatracurium as needed. Analgesia was 116 assured by the bupivacaine solution in the epidural group and by fentanyl as needed 117 in the PCA group. 118
At the end of surgery, a solution of bupivacaine 0.1%, fentanyl 2 µg/ml and 119 adrenaline 2 µg/ml was initiated in the epidural group at a rate of 6-10 ml/h (target: 120 VAS<4) with bolus of 3 ml of the solution allowed every 40 minutes (Patient 121
Controlled Epidural Analgesia) 20 . In the PCA group, iv PCA with morphine 1 mg/ml, 122 with bolus of 1 ml at every 5 minutes and a locked of 40 mg/4 hours was inserted. 123
All patients received paracetamol 4x1g/day and metamizole 4x500mg/day as 124 baseline analgesic treatment unless contraindicated. Pain assessment was done 125 twice daily at rest and on mobilization or coughing by a dedicated institutional 126 analgesia team. Failure of either technique (VAS persistently >3) was recorded by 127 the analgesia team and rescue pain relief was administered if necessary (morphine6 subcutaneously 0.1 mg/kg maximum 6x/d or buprenorphine sublingual 0.2-0.4 mg 129 maximum 3x/d). Both interventions were planned to be discontinued on postoperative 130 day (POD) 2 following international recommendations 21, 22 . EDA and PCA could be 131 continued if the analgesia team judged that a prolonged application was beneficial for 132 the patient. The day of discontinuation was documented. 133
During anesthesia and for the following postoperative days, maintenance of 134 blood pressure >60mmHg or diuresis > 0.5 ml/kg/h was aimed for, first by 135 administration of volume, Ringer-lactate 500 ml or 500 ml colloids (Voluven
Noradrenaline at a dose of 0-10µg/h was used as vasopressor if blood pressure was 137 not corrected by volume administration. Substitution of blood products was done if 138 hematocrit < 25%, or at the discretion of the anesthetist in charge of the procedure. 139
140

Perioperative care pathway 141
Enhanced recovery was introduced in our institution in 2006 using a protocol 142 which was adapted after a first randomized trial from our group subgroup analysis excluding patients with major complications was additionally 177
performed. 178
Primary and secondary endpoints depend not only on the allocated analgesic 179 intervention but also heavily on the global perioperative care strategy 3, 6, 15, 25 . were assessed for eligibility. 138 patients did not meet the inclusion criteria or 205 refused to participate. The remaining 128 patients were randomized to receive either 206 EDA (n=67) or PCA (n=61) as allocated treatment. Two EDA patients and four PCA 207 patients dropped out after randomization and no patient was lost to follow-up. Final 208 analysis compared therefore 65 EDA patients with 57 patients with PCA (Figure 1) . 209
Both comparative groups were similar in terms of pertinent demographic 210 parameters and surgical aspects as displayed in Table 1 . 211
212
Technical success rates and duration of EDA and PCA treatment 213
Eight EDA were judged non-functioning and removed consistently on POD 0 214 (n=2) and POD 1 (n=6). Overall failure rate was thus 12%. EDA and PCA were 215 (Figure 2) . Pain was overall well controlled by both modalities and no 249 significant differences were noted at any time point (Figure 3) . 250
251
Subgroup analysis 252
A tendency to more major complications was observed in the EDA group (15 253 vs. 5, P=0.213). As major complications have a significant impact on primary and 254 secondary outcome measures, a post hoc analysis was performed excluding patients 255 with major complications. Fifty EDA patients were compared with 52 PCA patients. 256
Medical recovery and high dependency stay were significantly shorter in the PCA 257 group (P=0.050 and P=0.010), respectively, while hospital stay was similar (Figure  258 
4).
The ERAS ® protocol was modified during the study period and the first 26 259 consecutive patients were not treated within the complete pathway as mentioned in . 295
Colon and rectal surgery differ considerably in terms of technique, surgical 296 trauma and early outcomes. The most recent ERAS ® recommendations were 297 therefore issued separately for the two entities 4, 5 . While the available data from the 298 present study and previous ones appears to be sufficient to abandon EDA for 299 laparoscopic colon resections, evidence is insufficient to for rectal resections as the 300 collectives in the respective randomized trials are too small 9, 10, 16 .
301
EDA failed in 12% of the patients in our study and was removed in 28% 302 patients after anticipated POD 2. These "deviations" disfavor the EDA group on the 303 one hand but reflect clinical realities on the other hand 8, 33 . Further, epidural 304 analgesia can be performed at different thoracic levels, and combination and 305 concentration of medications vary considerably. The results of our study can 306 therefore not be uncritically generalized to other settings. However, the institutional 307 technique applied in the present study and the reported success rates were in line 308 with recent publications and might therefore still be of interest for many institutions . 313
314
Several limitations need to be addressed. Both groups were well matched by 315 means of randomization. However, EDA patients experienced more overall and 316 major complications than patients with PCA. These were mainly unrelated 317 complications entailing a potential bias disfavoring the EDA group. Therefore, 318 patients with major complications were excluded in a post hoc subgroup analysis 319 because of an obvious impact on outcome. Postoperative pain management is 320 embedded in a global care scheme and the impact of EDA or other modalities on 321 recovery, pain relief and length of stay needs to be interpreted in this context. As 322 mentioned in the methods section, the enhanced recovery pathway was adapted 323 during the study period. In order to avoid the bias of various perioperative care 324 pathways and unbalanced major complications, a second subgroup analysis was 325 performed with all consecutive patients within the full ERAS ® pathway and without 326 major complications. The interesting point was that both subgroup analyses 327 confirmed the results of the main analysis according to the intention-to-treat principle, 328
and resulted in significantly reduced times for medical recovery and high dependency 329 stay in PCA patients. 330
331
In conclusion, the present study suggests that epidurals decrease blood 332 pressure in about one third of patients who therefore require transitory hemodynamic 333 support and a prolonged stay in a high dependency unit. Mean values ± standard deviation or no. of patients (%).
EDA -epidural analgesia, PCA -patient-controlled opioid-based analgesia, BMIbody mass index, ASA -American Society of Anesthetists, OR time -operation room time.
Online appendix A Postoperative complications by severity. EDA -epidural analgesia, PCA -patient-controlled opioid-based analgesia.
* indicates statistical significance (P<0.05).
Figure 3
Perioperative pain scores. EDA -epidural analgesia, PCA -patient-controlled opioid-based analgesia.
Data expressed as mean±SD.
